Risk Of Depression Increases With Severity Of Glaucoma, Age

Thursday, September 25, 2008

Comments

Ocular Surgery News

Geriatric glaucoma patients who have greater visual loss are more prone to depression than nonglaucoma patients of the same age, an increased risk that physicians should be aware of when treating patients, a study found.

Full Story

Glaucoma Testing Equipment / Glaucoma Products »

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?
1. Topical prednisolone acetate 1% (PredForte) QID
2. Topical ketorolac tromethamine (Acular) QID
3. Topical nepefanac (Nevanac) TID
4. Intravitreal triamcinolone acetonide(Kenalog) in 0.1 cc
5. None of the above
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Risk Of Depression Increases With Severity Of Glaucoma, Age

Comments

Related Categories

Glaucoma Testing Equipment / Glaucoma Products »

Quick Quiz

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?

AdGlare RMR Ad

Featured Products

CareCloud Central

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us